Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer’s disease

Frontiers in Behavioral Neuroscience

Volumn 8, Issue SEP, 2014, Pages

  Galeano, Pablo ^a,b   Martino Adami, Pamela V ^a   Carmo, Sonia Do ^c   Blanco, Eduardo ^d   Rotondaro, Cecilia ^a   Capani, Francisco ^b   Castaño, Eduardo M ^a   Claudio Cuello, A ^c   Morelli, Laura ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Alzheimer s disease; Amyloid ; Anxiety; Cognitive impairment; Transgenic rat models

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; GENOTYPE; HIPPOCAMPUS; IMMUNOREACTIVITY; LOCOMOTION; LONGITUDINAL STUDY; MEMORY CONSOLIDATION; MEMORY DISORDER; MORRIS WATER MAZE TEST; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OPEN FIELD TEST; RAT; REFERENCE MEMORY; SPATIAL LEARNING; SYMPTOMATOLOGY; WORKING MEMORY;

EID: 84908217409     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2014.00321     Document Type: Article

References (64)

1. Abbott, A. (2004). Laboratory animals: the Renaissance rat. Nature 428, 464-466. doi: 10.1038/428464a
2. Ally, B. A. (2012). Using pictures and words to understand recognition memory deterioration in amnestic mild cognitive impairment and Alzheimer’s disease: a review. Curr. Neurol. Neurosci. Rep. 12, 687-694. doi: 10.1007/s11910-012- 0310-7
3. Arendash, G. W., King, D. L., Gordon, M. N., Morgan, D., Hatcher, J. M., Hope, C. E., et al. (2001). Progressive, age-related behavioral impairments in trans- genic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res. 891, 42-53. doi: 10.1016/S0006-8993(00)03186-3
4. Baddeley, A. (2003). Working memory: looking back and looking forward. Nat. Rev. Neurosci. 4, 829-839. doi: 10.1038/nrn1201
5. Bateman, R. J., Xiong, C., Benzinger, T. L., Fagan, A. M., Goate, A., Fox, N. C., et al. (2012). Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N. Engl. J. Med. 367, 795-804. doi: 10.1056/NEJMoa1202753
6. Blanchard, J., Decorte, L., Nogues, X., and Micheau, J. (2009). Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition. Behav. Brain Res. 201, 147-157. doi: 10.1016/j.bbr.2009.02.005
7. Bondi, M. W., Jak, A. J., Delano-Wood, L., Jacobson, M. W., Delis, D. C., and Salmon, D. P. (2008). Neuropsychological contributions to the early identification of Alzheimer’s disease. Neuropsychol. Rev. 18, 73-90. doi: 10.1007/s11065-008-9054-1
8. Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R. G., and Thal, L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer’s disease. Psychol. Aging 14, 295-303. doi: 10.1037/0882-7974.14.2.295
9. Boon, W. C., Van Den Buuse, M., Wegener, N., Martin, S., Chua, H. K., Bush, A. I., et al. (2010). Behavioural phenotype of APPC100.V717F transgenic mice over-expressing a mutant Abeta-bearing fragment is associated with reduced NMDA receptor density. Behav. Brain Res. 209, 27-35. doi: 10.1016/j.bbr.2010.01.013
10. Chung, J. A., and Cummings, J. L. (2000). Neurobehavioral and neuropsychiatric symptoms in Alzheimer’s disease: characteristics and treatment. Neurol. Clin. 18, 829-846. doi: 10.1016/S0733-8619(05)70228-0
11. Cohen, R. M., Rezai-Zadeh, K., Weitz, T. M., Rentsendorj, A., Gate, D., Spivak, I., et al. (2013). A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric Aβ, and frank neuronal loss. J. Neurosci. 33, 6245-6256. doi: 10.1523/JNEUROSCI.3672-12.2013
12. Collie, A., and Maruff, P. (2000). The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci. Biobehav. Rev. 24, 365-374. doi: 10.1016/S0149-7634(00)00012-9
13. Corcoran, K. A., Lu, Y., Turner, R. S., and Maren, S. (2002). Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer’s disease. Learn. Mem. 9, 243-252. doi: 10.1101/lm.51002
14. D’Andrea, M. R., Nagele, R. G., Wang, H. Y., Peterson, P. A., and Lee, D. H. (2001). Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer’s disease. Histopathology 38, 120-134. doi: 10.1046/j.1365-2559.2001.01082.x
15. Devi, L., and Ohno, M. (2012). Mitochondrial dysfunction and accumulation of the β-secretase-cleaved C-terminal fragment of APP in Alzheimer’s disease transgenic mice. Neurobiol. Dis. 45, 417-424. doi: 10.1016/j.nbd.2011.09.001
16. Dineley, K. T., Xia, X., Bui, D., Sweatt, J. D., and Zheng, H. (2002). Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J. Biol. Chem. 277, 22768-22780. doi: 10.1074/jbc.M200164200
17. Do Carmo, S., and Cuello, A. C. (2013). Modeling Alzheimer’s disease in transgenic rats. Mol. Neurodegener. 8:37. doi: 10.1186/1750-1326-8-37
18. Echeverria, V., Ducatenzeiler, A., Alhonen, L., Janne, J., Grant, S. M., Wandosell, F., et al. (2004). Rat transgenic models with a phenotype of intracellular Abeta accumulation in hippocampus and cortex. J. Alzheimers Dis. 6, 209-219.
19. Ennaceur, A. (2010). One-trial object recognition in rats and mice: method- ological and theoretical issues. Behav. Brain Res. 215, 244-254. doi: 10.1016/j.bbr.2009.12.036
20. Ennaceur, A., and Delacour, J. (1988). A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 31, 47-59. doi: 10.1016/0166-4328(88)90157-X
21. Eustache, F., Giffard, B., Rauchs, G., Chételat, G., Piolino, P., and Desgranges, B. (2006). Alzheimer’s disease and human memory. Rev. Neurol. (Paris) 162, 929-939. doi: 10.1016/S0035-3787(06)75102-5
22. Gainotti, G., Quaranta, D., Vita, M. G., and Marra, C. (2014). Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer’s disease. J. Alzheimers Dis. 38, 481-495. doi: 10.3233/JAD-130881
23. Galeano, P., Blanco Calvo, E., Madureira De Oliveira, D., Cuenya, L., Kamenetzky, G. V., Mustaca, A. E., et al. (2011). Long-lasting effects of perinatal asphyxia on exploration, memory and incentive downshift. Int. J. Dev. Neurosci. 29, 609-619. doi: 10.1016/j.ijdevneu.2011.05.002
24. Geda, Y. E., Schneider, L. S., Gitlin, L. N., Miller, D. S., Smith, G. S., Bell, J., et al. (2013). Neuropsychiatric symptoms in Alzheimer’s disease: past progress and anticipation of the future. Alzheimers Dement. 9, 602-608. doi: 10.1016/j.jalz.2012.12.001
25. Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., et al. (2000). Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156, 15-20. doi: 10.1016/S0002-9440(10)64700-1
26. Gundersen, H. J., and Jensen, E. B. (1987). The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229-263. doi: 10.1111/j.1365-2818.1987.tb02837.x
27. Holmes, A. (2001). Targeted gene mutation approaches to the study of anxiety- like behavior in mice. Neurosci. Biobehav. Rev. 25, 261-273. doi: 10.1016/S0149-7634(01)00012-4
28. Iulita, M. F., Allard, S., Richter, L., Munter, L. M., Ducatenzeiler, A., Weise, C., et al. (2014). Intracellular Aβ pathology and early cognitive impairments in a transgenic rat model overexpressing human amyloid precursor protein: a multidimensional study. Acta Neuropathol. Commun. 2:61. doi: 10.1186/2051-5960-2-61
29. Kloskowska, E., Pham, T. M., Nilsson, T., Zhu, S., Oberg, J., Codita, A., et al. (2010). Cognitive impairment in the Tg6590 transgenic rat model of Alzheimer’s disease. J. Cell. Mol. Med. 14, 1816-1823. doi: 10.1111/j.1582-4934.2009.00809.x
30. Kobayashi, D. T., and Chen, K. S. (2005). Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer’s disease. Genes Brain Behav. 4, 173-196. doi: 10.1111/j.1601-183X.2005.00124.x
31. Lalonde, R., Dumont, M., Fukuchi, K., and Strazielle, C. (2002). Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on spatial learning, exploration, anxiety, and motor coordination. Exp. Gerontol. 37, 1401-1412. doi: 10.1016/S0531-5565(02)00123-7
32. Lalonde, R., Fukuchi, K., and Strazielle, C. (2012). APP transgenic mice for mod- elling behavioural and psychological symptoms of dementia (BPSD). Neurosci. Biobehav. Rev. 36, 1357-1375. doi: 10.1016/j.neubiorev.2012.02.011
33. Laurijssens, B., Aujard, F., and Rahman, A. (2013). Animal models of Alzheimer’s disease and drug development. Drug Discov. Today Technol. 10, e319-327. doi: 10.1016/j.ddtec.2012.04.001
34. Leal, M. C., Dorfman, V. B., Gamba, A. F., Frangione, B., Wisniewski, T., Castaño, E. M., et al. (2006). Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology. J. Neuropathol. Exp. Neurol. 65, 976-987. doi: 10.1097/01.jnen.0000235853.70092.ba
35. Le Cudennec, C., Faure, A., Ly, M., and Delatour, B. (2008). One-year longitudinal evaluation of sensorimotor functions in APP751SL transgenic mice. Genes Brain Behav. 7, 83-91. doi: 10.1111/j.1601-183X.2007.00374.x
36. Lee, K. W., Im, J. Y., Song, J. S., Lee, S. H., Lee, H. J., Ha, H. Y., et al. (2006). Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. Neurobiol. Dis. 22, 10-24. doi: 10.1016/j.nbd.2005.09.011
37. Lee, K. W., Lee, S. H., Kim, H., Song, J. S., Yang, S. D., Paik, S. G., et al. (2004). Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. J. Neurosci. Res. 76, 572-580. doi: 10.1002/jnr.20127
38. Leon, W. C., Canneva, F., Partridge, V., Allard, S., Ferretti, M. T., Dewilde, A., et al. (2010). A novel transgenic rat model with a full Alzheimer’s-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment. J. Alzheimers Dis. 20, 113-126. doi: 10.3233/JAD-2010-1349
39. Mehta, N. S., Wang, L., and Redei, E. E. (2013). Sex differences in depressive, anxious behaviors and hippocampal transcript levels in a genetic rat model. Genes Brain Behav. 12, 695-704. doi: 10.1111/gbb.12063
40. Mitani, Y., Yarimizu, J., Akashiba, H., Shitaka, Y., Ni, K., and Matsuoka, N. (2013). Amelioration of cognitive deficits in plaque-bearing Alzheimer’s disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools. J. Neurochem. 125, 465-472. doi: 10.1111/jnc.12125
41. Moran, P. M., Higgins, L. S., Cordell, B., and Moser, P. C. (1995). Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human beta-amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A. 92, 5341-5345. doi: 10.1073/pnas.92.12.5341
42. Nagahara, A. H., Mateling, M., Kovacs, I., Wang, L., Eggert, S., Rockenstein, E., et al. (2013). Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice. J. Neurosci. 33, 15596-15602. doi: 10.1523/JNEUROSCI.5195-12.2013
43. Ohno, M., Sametsky, E. A., Younkin, L. H., Oakley, H., Younkin, S. G., Citron, M., et al. (2004). BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer’s disease. Neuron 41, 27-33. doi: 10.1016/S0896-6273(03)00810-9
44. Paxinos, G., and Watson, C. (2009). The Rat Brain in Stereotaxic Coordinates: Compact, 6th Edn. New York, NY: Academic Press.
45. Pellow, S., Chopin, P., File, S. E., and Briley, M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14, 149-167. doi: 10.1016/0165-0270(85)90031-7
46. Pinton, S., Da Rocha, J. T., Gai, B. M., and Nogueira, C. W. (2011). Sporadic dementia of Alzheimer’s type induced by streptozotocin promotes anxiogenic behavior in mice. Behav. Brain Res. 223, 1-6. doi: 10.1016/j.bbr.2011.04.014
47. Ramos, A. (2008). Animal models of anxiety: do I need multiple tests? Trends Pharmacol. Sci. 29, 493-498. doi: 10.1016/j.tips.2008.07.005
48. Ramos, A., Mellerin, Y., Mormède, P., and Chaouloff, F. (1998). A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav. Brain Res. 96, 195-205. doi: 10.1016/S0166-4328(98)00023-0
49. Savonenko, A. V., Xu, G. M., Price, D. L., Borchelt, D. R., and Markowska, A. L. (2003). Normal cognitive behavior in two distinct congenic lines of transgenic mice hyperexpressing mutant APP SWE. Neurobiol. Dis. 12, 194-211. doi: 10.1016/S0969-9961(02)00012-8
50. Scahill, R. I., Schott, J. M., Stevens, J. M., Rossor, M. N., and Fox, N. C. (2002). Mapping the evolution of regional atrophy in Alzheimer’s disease: Galeano et al. Rat model of early AD unbiased analysis of fluid-registered serial MRI. Proc. Natl. Acad. Sci. U.S.A. 99, 4703-4707. doi: 10.1073/pnas.052587399
51. Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., and Markesbery, W. R. (2000). “Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology 55, 370-376. doi: 10.1212/WNL.55.3.370
52. Senanarong, V., Cummings, J. L., Fairbanks, L., Mega, M., Masterman, D. M., and O’Connor, S. M. (2004). Agitation in Alzheimer’s disease is a manifesta- tion of frontal lobe dysfunction. Dement. Geriatr. Cogn. Disord. 17, 14-20. doi: 10.1159/000074080
53. Sierksma, A. S., Van Den Hove, D. L., Pfau, F., Philippens, M., Bruno, O., Fedele, E., et al. (2014). Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D. Neuropharmacology 77, 120-130. doi: 10.1016/j.neuropharm.2013.09.015
54. Smith, G. E., Pankratz, V. S., Negash, S., Machulda, M. M., Petersen, R. C., Boeve, B. F., et al. (2007). A plateau in pre-Alzheimer memory decline: evidence for compensatory mechanisms? Neurology 69, 133-139. doi: 10.1212/01.wnl.0000265594.23511.16
55. Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 280-292. doi: 10.1016/j.jalz.2011.03.003
56. Trullas, R., and Skolnick, P. (1993). Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology (Berl.) 111, 323-331. doi: 10.1007/BF02244948
57. Tybout, A., Sternthal, B., Keppel, G., Verducci, J., Meyers-Levy, J., Barnes, J., et al. (2001). Analysis of Variance. J. Consum. Psychol. 10, 5-35. doi: 10.1207/S15327663JCP1001&2_03
58. Vellas, B., Carrillo, M. C., Sampaio, C., Brashear, H. R., Siemers, E., Hampel, H., et al. (2013). Designing drug trials for Alzheimer’s disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement. 9, 438-444. doi: 10.1016/j.jalz.2013.03.007
59. Verma, P., Hellemans, K. G., Choi, F. Y., Yu, W., and Weinberg, J. (2010). Circadian phase and sex effects on depressive/anxiety-like behaviors and HPA axis responses to acute stress. Physiol. Behav. 99, 276-285. doi: 10.1016/j.physbeh.2009.11.002
60. Vorhees, C. V., and Williams, M. T. (2006). Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848-858. doi: 10.1038/nprot.2006.116
61. Walsh, R. N., and Cummins, R. A. (1976). The Open-Field Test: a critical review. Psychol. Bull. 83, 482-504. doi: 10.1037/0033-2909.83.3.482
62. Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A., and Van Eldik, L. J. (2014). Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front. Genet. 5:88. doi: 10.3389/fgene.2014.00088
63. Whishaw, I. Q., Metz, G. A., Kolb, B., and Pellis, S. M. (2001). Accelerated nervous system development contributes to behavioral efficiency in the laboratory mouse: a behavioral review and theoretical proposal. Dev. Psychobiol. 39, 151-170. doi: 10.1002/dev.1041
64. Wietrzych, M., Meziane, H., Sutter, A., Ghyselinck, N., Chapman, P. F., Chambon, P., et al. (2005). Working memory deficits in retinoid X receptor gamma-deficient mice. Learn. Mem. 12, 318-326. doi: 10.1101/lm.89805